During the past decade, Mehrdad Kevin Ariani, MD, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mehrdad Kevin Ariani, MD, Inc." #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mehrdad Kevin Ariani, MD, Inc." are "Cardiovascular Diseases" (1 trials), "Heart Diseases" (1 trials), "Heart Failure, Congestive" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Mehrdad Kevin Ariani, MD, Inc." in a lesser frequency.

Most popular intervention types in "Mehrdad Kevin Ariani, MD, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (1 trials), "Metformin XR" (1 trials), "Placebo" (1 trials), "Placebo matching with Dapagliflozin" (1 trials) and "Placebo matching with Saxagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mehrdad Kevin Ariani, MD, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mehrdad Kevin Ariani, MD, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mehrdad Kevin Ariani, MD, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mehrdad Kevin Ariani, MD, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".